EA202092477A1 - ANTIBODIES AGAINST GALECTIN-10 - Google Patents

ANTIBODIES AGAINST GALECTIN-10

Info

Publication number
EA202092477A1
EA202092477A1 EA202092477A EA202092477A EA202092477A1 EA 202092477 A1 EA202092477 A1 EA 202092477A1 EA 202092477 A EA202092477 A EA 202092477A EA 202092477 A EA202092477 A EA 202092477A EA 202092477 A1 EA202092477 A1 EA 202092477A1
Authority
EA
Eurasian Patent Office
Prior art keywords
galectin
antibodies against
against galectin
antagonists
antibodies
Prior art date
Application number
EA202092477A
Other languages
Russian (ru)
Inventor
Барт Ламбрехт
Саввас Саввидес
Хамида Хаммад
Кеннет Верстрате
Жан-Мишель Персье
Кристоф Бланхетот
Майкл Сондерс
Ханс Де Хард
Бас Ван Дер Вонинг
Эмма Перссон
Original Assignee
Ардженкс Бвба
Виб Взв
Университейт Гент
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ардженкс Бвба, Виб Взв, Университейт Гент filed Critical Ардженкс Бвба
Priority claimed from PCT/EP2019/059570 external-priority patent/WO2019197675A1/en
Publication of EA202092477A1 publication Critical patent/EA202092477A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к антагонистам, а в частности к антителам и их антигенсвязывающим фрагментам, которые связываются с белком галектином-10, а в частности с человеческим галектином-10. Антагонисты галектина-10 нарушают кристаллизацию галектина-10 и, следовательно, могут быть использованы в способах профилактики и лечения заболеваний и состояний, при которых патология ассоциируется с образованием/присутствием кристаллов Шарко-Лейдена (CLC).The present invention relates to antagonists, and in particular to antibodies and antigen-binding fragments thereof, which bind to the galectin-10 protein, and in particular to human galectin-10. Galectin-10 antagonists interfere with the crystallization of galectin-10 and, therefore, can be used in methods for the prevention and treatment of diseases and conditions in which pathology is associated with the formation / presence of Charcot-Leiden crystals (CLC).

EA202092477A 2019-02-06 2019-04-12 ANTIBODIES AGAINST GALECTIN-10 EA202092477A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1901648.4A GB201901648D0 (en) 2019-02-06 2019-02-06 Galectin-10 antibodies
PCT/EP2019/059570 WO2019197675A1 (en) 2018-04-13 2019-04-12 Galectin-10 antibodies

Publications (1)

Publication Number Publication Date
EA202092477A1 true EA202092477A1 (en) 2021-03-29

Family

ID=65996882

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092477A EA202092477A1 (en) 2019-02-06 2019-04-12 ANTIBODIES AGAINST GALECTIN-10

Country Status (2)

Country Link
EA (1) EA202092477A1 (en)
GB (1) GB201901648D0 (en)

Also Published As

Publication number Publication date
GB201901648D0 (en) 2019-03-27

Similar Documents

Publication Publication Date Title
MX2020010821A (en) Galectin-10 antibodies.
EA202092605A1 (en) ANTIBODIES TO IL-11RA
EA202092668A1 (en) ANTIBODIES TO IL-11
EA201890039A1 (en) ANTIBODIES SPECIFIC TO HYPERPHOSPHORYLATED TAU-PROTEIN, AND METHODS OF THEIR APPLICATION
PH12021550023A1 (en) Humanized anti-tau antibodies
EA201792221A1 (en) ANTIBODIES AGAINST SORTILINE AND METHODS OF THEIR APPLICATION
EA202092933A1 (en) ANTIBODIES TO ENTPD2, TYPES OF COMBINATION THERAPY AND METHODS OF APPLICATION OF ANTIBODIES AND TYPES OF COMBINATION THERAPY
EA201891178A1 (en) Bispecific molecules possessing immunoreactivity with respect to PD-1 and CTLA-4, and methods of their use
EA201992163A1 (en) ANTIBODIES TO N3pGlu BETA AMYLOID PEPTIDE AND THEIR APPLICATION
EA201270813A1 (en) ANTIBODIES TO N3pGlu BETA AMYLOID PEPTIDE AND THEIR APPLICATION
EA201492149A1 (en) ST2 Antigen Binding Proteins
EA201391761A1 (en) ANTI-ALPHA-SINUCLAIN-BINDING MOLECULES
EA201170716A1 (en) ANTIBODIES TO C-MET
MX2019007500A (en) Antagonists of il-6 to raise albumin and/or lower crp.
EA202190138A1 (en) ANTI-SIRP-BETA1 ANTIBODIES AND METHODS OF THEIR USE
EA201490020A1 (en) SOLUBLE PROTEINS FOR USE AS THERAPEUTIC TOOLS
EA200900037A1 (en) MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN-6 (IL-6) AND THEIR APPLICATION
EA202092420A1 (en) ANTIBODY AGAINST PD-L1 AND ITS APPLICATION
EA201991511A1 (en) GREMLIN-1 CRYSTAL STRUCTURE AND AN INHIBITING ANTIBODY
EA202091747A1 (en) ANTIBODY B7-H4 COMPOSITIONS
EA201992570A1 (en) COMPOSITIONS BASED ON HUMAN ANTIBODIES TO RANKL, AND ALSO WAYS OF THEIR APPLICATION
EA201890928A1 (en) ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
EA202190094A1 (en) ANTIBODIES AGAINST CD40 FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASE
EA202192907A1 (en) MONOCLONAL ANTIBODY THAT SPECIFICLY BINDS TO GITR
EA202190183A1 (en) ANTIBODIES TO SIGLEC-5 AND METHODS OF THEIR APPLICATION